BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30706680)

  • 41. Society for Maternal-Fetal Medicine Consult Series #57: Evaluation and management of isolated soft ultrasound markers for aneuploidy in the second trimester: (Replaces Consults #10, Single umbilical artery, October 2010; #16, Isolated echogenic bowel diagnosed on second-trimester ultrasound, August 2011; #17, Evaluation and management of isolated renal pelviectasis on second-trimester ultrasound, December 2011; #25, Isolated fetal choroid plexus cysts, April 2013; #27, Isolated echogenic intracardiac focus, August 2013).
    ; Prabhu M; Kuller JA; Biggio JR
    Am J Obstet Gynecol; 2021 Oct; 225(4):B2-B15. PubMed ID: 34171388
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
    Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Case Report of a Feto-Placental Mosaicism Involving a Segmental Aneuploidy: A Challenge for Genome Wide Screening by Non-Invasive Prenatal Testing of Cell-Free DNA in Maternal Plasma.
    De Falco L; Vitiello G; Savarese G; Suero T; Ruggiero R; Savarese P; Ianniello M; Petrillo N; Bruno M; Legnante A; Passaretti FF; Ardisia C; Di Spiezio Sardo A; Fico A
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980940
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Application of non-invasive prenatal testing in late gestation in a pregnancy associated with intrauterine growth restriction and trisomy 22 confined placental mosaicism.
    Chen CP; Tsai C; Lin MH; Chern SR; Chen SW; Lai ST; Chen WL; Pan CW; Wang W
    Taiwan J Obstet Gynecol; 2017 Oct; 56(5):691-693. PubMed ID: 29037560
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Placental, maternal, fetal, and technical origins of false-positive cell-free DNA screening results.
    Raymond Y; Fernando S; Menezes M; Mol BW; McLennan A; da Silva Costa F; Hardy T; Rolnik DL
    Am J Obstet Gynecol; 2024 Apr; 230(4):381-389. PubMed ID: 38008147
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discrepancy between Non-invasive Prenatal Genetic Testing (NIPT) and Amniotic Chromosomal Test due to Placental Mosaicism: A Case Report and Literature Review.
    Hayata K; Hiramatsu Y; Masuyama H; Eto E; Mitsui T; Tamada S
    Acta Med Okayama; 2017 Apr; 71(2):181-185. PubMed ID: 28420901
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical Application of Noninvasive Prenatal Testing for Pregnant Women with Assisted Reproductive Pregnancy.
    Jin XX; Xu YF; Ying X; Qian YQ; Jin PZ; Dong MY
    Int J Womens Health; 2021; 13():1167-1174. PubMed ID: 34876859
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Combining Effects of Cell-Free Circulating Tumor DNA of Breast Tumor to the Noninvasive Prenatal Testing Results: A Simulating Investigation.
    Cai YH; Yao GY; Chen LJ; Gan HY; Ye CS; Yang XX
    DNA Cell Biol; 2018 Jul; 37(7):626-633. PubMed ID: 29957029
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of maternal X chromosome abnormalities using single nucleotide polymorphism-based noninvasive prenatal testing.
    Martin KA; Samango-Sprouse CA; Kantor V; Dhamankar R; Valenti E; Trefogli MT; Balosbalos I; Lagrave D; Lyons D; Kao C; Hakonarson H; Billings PR
    Am J Obstet Gynecol MFM; 2020 Aug; 2(3):100152. PubMed ID: 33345882
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prenatal cytogenetic and molecular genetic analysis of a fetus with confined placenta mosaicism for trisomy 16].
    Jiao Z; Zhu C; Hou Y; Wang L; Kong X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Aug; 38(8):771-774. PubMed ID: 34365622
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Noninvasive prenatal screening in twin pregnancies with cell-free DNA using the IONA test: a prospective multicenter study.
    Khalil A; Archer R; Hutchinson V; Mousa HA; Johnstone ED; Cameron MJ; Cohen KE; Ioannou C; Kelly B; Reed K; Hulme R; Papageorghiou AT
    Am J Obstet Gynecol; 2021 Jul; 225(1):79.e1-79.e13. PubMed ID: 33460583
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isochromosome 21q is overrepresented among false-negative cell-free DNA prenatal screening results involving Down syndrome.
    Huijsdens-van Amsterdam K; Page-Christiaens L; Flowers N; Bonifacio MD; Ellis KMB; Vogel I; Vestergaard EM; Miguelez J; de Carvalho MHB; Sistermans EA; Pertile MD
    Eur J Hum Genet; 2018 Oct; 26(10):1490-1496. PubMed ID: 29899373
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of the results of non-invasive prenatal testing (NIPT) in 545 pregnant women in advanced maternal age.
    Su JY; Wei YN; Chen HF; Tong JR; Chen Y; Deng L; Huang LL; Zhang LY
    Eur Rev Med Pharmacol Sci; 2023 Aug; 27(15):7101-7106. PubMed ID: 37606120
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Non invasive prenatal test (NIPT) in maternal blood by parallel massive sequencing. Initial experience in Mexican women and literature review].
    Hernández-Gómez M; Ramirez-Arroyo E; Meléndez-Hernández R; Garduño-Zaraza LM; Mayén-Molina DG
    Ginecol Obstet Mex; 2015 May; 83(5):277-88. PubMed ID: 26233973
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Confined placental origin of the circulating cell free fetal DNA revealed by a discordant non-invasive prenatal test result in a trisomy 18 pregnancy.
    Mao J; Wang T; Wang BJ; Liu YH; Li H; Zhang J; Cram D; Chen Y
    Clin Chim Acta; 2014 Jun; 433():190-3. PubMed ID: 24667696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Late first-trimester ultrasound findings can alter management after high-risk NIPT result.
    Scott F; Smet ME; Elhindi J; Mogra R; Sunderland L; Ferreira A; Menezes M; Meagher S; McLennan A
    Ultrasound Obstet Gynecol; 2023 Oct; 62(4):497-503. PubMed ID: 37247395
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Confirmatory testing illustrates additional risks for structural sex chromosome abnormalities in fetuses with a non-invasive prenatal screen positive for monosomy X.
    Sund KL; Khattar D; Boomer T; Caldwell S; Dyer L; Hopkin RJ; Smolarek TA
    Am J Med Genet C Semin Med Genet; 2020 Jun; 184(2):294-301. PubMed ID: 32476283
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Maternal Plasma DNA and RNA Sequencing for Prenatal Testing.
    Tamminga S; van Maarle M; Henneman L; Oudejans CB; Cornel MC; Sistermans EA
    Adv Clin Chem; 2016; 74():63-102. PubMed ID: 27117661
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Case Report: Challenges of Non-Invasive Prenatal Testing (NIPT): A Case Report of Confined Placental Mosaicism and Clinical Considerations.
    Bonanni G; Trevisan V; Zollino M; De Santis M; Romanzi F; Lanzone A; Bevilacqua E
    Front Genet; 2022; 13():881284. PubMed ID: 35646091
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
    Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
    Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.